Cardiovascular risk factors in women with primary Sjögren's syndrome: United Kingdom primary Sjögren's syndrome registry results.

M Juarez, T E Toms, P de Pablo, S Mitchell, S Bowman, P Nightingale, E J Price, B Griffiths, J Hunter, M Gupta, M Bombardieri, N Sutdliffe, C Pitzalis, C Pease, J Andrews, P Emery, M Regan, I Giles, D Isenberg, R Moots, K S Collins, W F Ng, G D Kitas, UK Primary Sjögren’s Syndrome Registry
Author Information

Abstract

OBJECTIVE: To determine the prevalence of traditional cardiovascular risk factors using established definitions in a large cohort of clinically well-characterized primary Sjögren's syndrome (SS) patients and to compare them to healthy controls.
METHODS: Data on cardiovascular risk factors in primary SS patients and controls were collected prospectively using a standardized pro forma. Cardiovascular risk factors were defined according to established definitions. The prevalence of cardiovascular risk factors in the primary SS group was determined and compared to that in the control group.
RESULTS: Primary SS patients had a higher prevalence of hypertension (28–50% versus 15.5–25.6%; P < 0.01) and hypertriglyceridemia (21% versus 9.5%; P = 0.002) than age- and sex-matched healthy controls. Furthermore, a significant percentage (56%) of hypertensive patients expected to be on antihypertensive treatment according to best practice was not receiving it.
CONCLUSION: Primary SS patients are more than 2 times more likely to experience hypertension and hypertriglyceridemia than age- and sex-matched healthy controls. Additionally, hypertension is underdiagnosed and suboptimally treated in primary SS.

References

  1. Circulation. 2005 Nov 22;112(21):3337-47 [PMID: 16301360]
  2. Arthritis Rheum. 2005 Dec;52(12):3890-7 [PMID: 16320337]
  3. Endothelium. 2008 Jul-Aug;15(4):203-12 [PMID: 18663623]
  4. Rheumatology (Oxford). 2006 Apr;45(4):481-4 [PMID: 16303821]
  5. Occup Med (Lond). 1999 May;49(4):225-9 [PMID: 10474913]
  6. Rheumatology (Oxford). 2011 Jan;50(1):32-9 [PMID: 20693261]
  7. Diabet Med. 1998 Jul;15(7):539-53 [PMID: 9686693]
  8. Arthritis Res Ther. 2012 Dec 13;14(6):R270 [PMID: 23237607]
  9. Ann Rheum Dis. 2010 Feb;69(2):325-31 [PMID: 19773290]
  10. Circulation. 2004 Dec 21;110(25):e543-4 [PMID: 15611378]
  11. Expert Rev Mol Med. 2005 May 06;7(7):1-24 [PMID: 15876361]
  12. Best Pract Res Clin Rheumatol. 2009 Aug;23(4):481-94 [PMID: 19591779]
  13. N Engl J Med. 2003 Dec 18;349(25):2399-406 [PMID: 14681505]
  14. J Rheumatol. 1997 Mar;24(3):445-51 [PMID: 9058647]
  15. Lupus. 2010 Jul;19(8):941-8 [PMID: 20581017]
  16. Arthritis Rheum. 2001 Dec;44(12):2737-45 [PMID: 11762933]
  17. Rheumatology (Oxford). 2009 Feb;48(2):113-8 [PMID: 19106168]
  18. J Rheumatol. 1999 Nov;26(11):2475-9 [PMID: 10555912]
  19. JAMA. 2001 May 16;285(19):2486-97 [PMID: 11368702]
  20. Ann Rheum Dis. 2002 Jun;61(6):554-8 [PMID: 12006334]
  21. Clin Rheumatol. 2009 May;28(5):587-90 [PMID: 19205787]
  22. Arthritis Rheum. 2002 Apr;46(4):862-73 [PMID: 11953961]
  23. Ann Rheum Dis. 2011 Jun;70(6):881-3 [PMID: 21450751]
  24. Am Heart J. 2011 Feb;161(2):344-50 [PMID: 21315218]
  25. Curr Vasc Pharmacol. 2010 May;8(3):301-26 [PMID: 19758115]
  26. Joint Bone Spine. 2010 May;77(3):229-31 [PMID: 20378384]
  27. Am J Hypertens. 1994 Jul;7(7 Pt 2):7S-12S [PMID: 7946184]
  28. Rheumatology (Oxford). 2007 Sep;46(9):1477-82 [PMID: 17704521]
  29. BMJ. 2010 May 27;340:c2451 [PMID: 20508025]
  30. Autoimmun Rev. 2002 Dec;1(6):338-47 [PMID: 12848989]

Grants

  1. 18475/Arthritis Research UK
  2. 18475/Versus Arthritis
  3. G0800629/Medical Research Council

MeSH Term

Adult
Aged
Cardiovascular Diseases
Cohort Studies
Female
Humans
Hypertension
Hypertriglyceridemia
Male
Middle Aged
Prospective Studies
Registries
Risk Factors
Sjogren's Syndrome
United Kingdom

Word Cloud

Created with Highcharts 10.0.0primarySSriskfactorspatientscontrolsprevalencecardiovascularSjögren'shealthyhypertensionusingestablisheddefinitionssyndromeCardiovascularaccordinggroupPrimaryversusP0hypertriglyceridemiaage-sex-matchedOBJECTIVE:determinetraditionallargecohortclinicallywell-characterizedcompareMETHODS:DatacollectedprospectivelystandardizedproformadefineddeterminedcomparedcontrolRESULTS:higher28–50%155–256%<0121%95%=002Furthermoresignificantpercentage56%hypertensiveexpectedantihypertensivetreatmentbestpracticereceivingitCONCLUSION:2timeslikelyexperienceAdditionallyunderdiagnosedsuboptimallytreatedwomensyndrome:UnitedKingdomregistryresults

Similar Articles

Cited By